Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ASTRAZENECA-PLC-4000930/news/AstraZeneca-BRILINTA-Met-Primary-Endpoint-in-the-Phase-III-THALES-Trial-in-Stroke-29895193/?utm_source=whatsapp&utm_medium=social&utm_campaign=share